Qualitative membrane enzyme immunoassay for detection of cytomegalovirus antibody

Area of Science:

• Clinical Virology
• Immunological Assays
• Diagnostic Microbiology

Background:

• Cytomegalovirus (CMV) IgG antibodies are crucial markers for past infection.
• Accurate detection of CMV IgG antibodies aids in understanding immune status.
• Existing diagnostic methods may require specialized equipment or longer processing times.

Purpose of the Study:

• To evaluate a novel qualitative membrane immunoassay for detecting cytomegalovirus (CMV) IgG antibodies.
• To compare the performance of the new membrane immunoassay against a standard microplate enzyme immunoassay (EIA).
• To assess the reliability and ease of use of the membrane immunoassay.

Main Methods:

• A total of 179 patient sera were tested.
• Sera were analyzed using a standard microplate enzyme immunoassay (EIA) for CMV IgG and IgM antibodies.
• The new Transtat-CMV qualitative membrane immunoassay was used for comparison.
• Performance metrics were calculated based on evaluable sera.

Main Results:

• Out of 179 sera, 5 were repeatably invalid, leaving 174 evaluable samples.
• The EIA identified 128 sera (73.6%) as positive for CMV IgG antibodies.
• The Transtat-CMV assay correctly identified 124 of these 128 positive sera (96.9% sensitivity).
• All 46 sera negative by EIA were also negative by the membrane assay.

Conclusions:

• The Transtat-CMV membrane immunoassay demonstrates high reliability for qualitative detection of CMV IgG antibodies.
• The assay is user-friendly, requires no additional equipment, and has short incubation times.
• As a qualitative assay, it is suitable for screening but not for definitive diagnosis.